Bass Society Pediatric Scholars


Sharon Rebecca Chinthrajah, MD   
The Carell Family Endowed Faculty Scholar for Food Allergy and Immunology Research (2015-2017)
Clinical Assistant Professor of Allergy and Immunology and Pulmonary/Critical Care Medicine

Education: 
BS, Lehigh University, 2000
MD, Drexel University College of Medicine, 2004
Residency, California Pacific Medical Center, 2008
Fellowship (Pulmonary/Critical Care Medicine), Boston Medical Center, 2011
Fellowship (Allergy & Immunology), Boston Medical Center, 2013
MD, Drexel University College of Medicine, 2004

Research focus: Dr. Chinthrajah’s research focuses on advancing the understanding of immune dysfunction and regulation in atopic diseases such as food allergy and asthma. As a co-investigator at the Sean N. Parker Center for Allergy Research, Dr. Chinthrajah conducts clinical trials to investigate novel therapeutic approaches in allergic individuals. By understanding the mechanisms of immune regulation in patients undergoing therapy, she can then apply these principles to understand pathogenesis of disease. With the hope of understanding organ specific mechanisms, Dr. Chinthrajah’s team has active protocols to obtain samples from allergic patients in order to develop a comprehensive overview of immune networks.   


Tushar Desai, MD, MPH
Woods Family Endowed Faculty Scholar in Translational Medicine (2016-2021)
Assistant Professor of Medicine - Pulmonary and Critical Care Medicine

Education:
BA, Amherst College, 1991
MD, Tufts University School of Medicine, 1995
MPH, Tufts University School of Medicine, 1995
Internship & Residency (Internal Medicine), University of Michigan Hospitals, 1998
Fellowship (Pulmonary and Critical Care), Boston Medical Center, 2004
Postdoctoral Fellowship (Biochemistry), Stanford University School of Medicine, 2008

Research focus:
Dr. Desai investigates the underlying cause of serious lung diseases like bronchopulmonary dysplasia, pulmonary fibrosis, emphysema, and lung cancer. By identifying the “engine” that drives a particular lung disease, he aims to devise specific treatments that target the underlying problem and, therefore, have the potential to halt the entire disease process. His laboratory’s approach is to first acquire a deep understanding of the normal cellular and molecular processes that regulate development and maintenance of a healthy lung and then to use this knowledge to infer which specific process has gone awry in a particular lung disease. Dr. Desai is particularly interested in determining if stem cell dysfunction contributes to lung diseases, since they represent a possible novel therapy that could easily be delivered into the lungs via the airways.


Chitra Dinakar, MD
Gies Foundation Endowed Faculty Scholar for Food Allergy and Immunology Research (2016-2021)
Professor of Pediatrics

Education:
MBBS, Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), India, 1990
MD, Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), India, 1993
Residency, MetroHealth Medical Center/Case Western Reserve University, 1996
Fellowship, Cleveland Clinic, 1999

Research focus:
Dr. Dinakar is passionate about caring for individuals with allergic and immunological disorders and improving the quality and delivery of their health care. Her research interests include asthma, food allergies, adherence, and health care quality and outcomes. Dr. Dinakar initiates and contributes to clinical research and translational studies at the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She received the 2015 American College of Allergy, Asthma, and Immunology Woman in Allergy Award for her leadership, dedication, and commitment to advancing the specialty.

Mentor: Kari C. Nadeau, MD, PhD 


Brian Feldman, MD, PhD
Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine (2012-2017)
Assistant Professor, Pediatrics - Endocrinology & Diabetes

Education: 
BA, Brandeis University, 1993
MD, Stanford University School of Medicine, 2001
PhD, Stanford University, 2001
Residency, Children’s Hospital Boston, 2004
Fellowship, University of California, San Francisco, 2006

Research focus: Dr. Feldman’s research investigates the role of the endocrine system in the health and development of diseases. His laboratory aims to increase the understanding of important physiological processes that are controlled by hormones, and determine how alterations in hormone levels disturb the body’s homeostasis and cause disease. His recent work is focused on the important role of hormones in stem cell fate decisions. In addition, Dr. Feldman is leading a study that seeks to develop a rapid diagnostic device (point-of-care assay) for diabetes that could be used anywhere in the world. Dr. Feldman received a National Institutes of Health Director’s New Innovator Award to support his laboratory. He has received additional honors including a scholar award from the Pediatric Endocrine Society, the Young Investigator Award from the Society of Pediatric Research, and the Early Investigator Award from the Endocrine Society.

Mentors: Elizabeth Mellins, MD, and Seung Kim, MD, PhD


Maya Kumar, PhD
Bravo Family Endowed Faculty Scholar for Food Allergy and Immunology Research (2015-2017)
Director of Lung Development at the Sean N. Parker Center for Allergy and Asthma Research at Stanford and Instructor of Medicine, Pulmonary and Critical Care Medicine

Education:
BA, Williams College, 1996
Fulbright Fellowship, University of Geneva, Switzerland, 1997
PhD, Harvard University, 2003
Postdoctoral Fellowship, Stanford University, 2015

Research focus:
Dr. Kumar’s research focuses on understanding the biology of airway remodeling in asthma, a respiratory disease in which dysregulation of the airway smooth muscle (ASM) narrows the bronchial tubes, affecting an estimated 14% of the world’s children annually. Dr. Kumar’s research explores the cell behaviors that underlie airway remodeling in asthma and other smooth muscle diseases of the lung. She then defines which cells and cell behaviors lead to ASM expansion in asthma and identifies potential regulators of those behaviors. Her long-term goals are to understand the formation, maintenance, and asthmatic dysregulation of the airway wall to find ways to halt or reverse airway remodeling as a treatment of asthma in children.

Mentors: Kari C. Nadeau, MD, PhD


A. Desiree LaBeaud, MD, MS
Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine (2015-2020)
Associate Professor of Pediatrics - Infectious Diseases
 
Education:
BS, University of California, San Diego, 1996
MD, Medical College of Wisconsin, 2000
Residency, Rainbow Babies & Children’s Hospital, 2003
Fellowship, Rainbow Babies & Children’s Hospital, 2006
MS, Case Western Reserve University, 2009
 
Research focus:
Since the early 2000s, Dr. LaBeaud has devoted her efforts to better understanding the risk factors and long-term health consequences of arboviral infections, including Rift Valley fever, chikungunya, and dengue viruses. Currently, Dr. LaBeaud has two large field projects ongoing in Kenya. As a physician-scientist, she splits her time between research (75%) and clinical practice (25%), including travel clinic experience. Her research aims to improve diagnostics of arboviral infections, and her laboratory uses Luminex technology to build a new screening assay and to assess vaccine responses against multiple pathogens.


Norman Lacayo, MD
Laurie Kraus Lacob Faculty Scholar in Pediatric Translational Medicine (2016-2019)
Associate Professor of Pediatrics - Hematology and Oncology

Education:
BA, University of California, Berkeley, 1985
MD, University of California, San Francisco, 1989
Internship (Pediatrics), University of California Hospitals, San Francisco, 1990
Residency (Pediatrics), University of California Hospitals, San Francisco, 1992
Fellowship (Pediatric Hematology/Oncology), Lucile Packard Children’s Hospital Stanford, Stanford University School of Medicine, 1995

Research focus:
Dr. Lacayo’s research focuses on the discovery and evaluation of new biomarkers in childhood acute myeloid leukemia (AML). He was the first to describe gene expression signatures related to FLT3-ITD mutations in childhood AML and later pioneered the first studies of single cell network profiles (SCNP) in childhood AML and tested the use of SCNP and drug sensitivity in clinical AML samples to determine its feasibility as a real-time clinical test. Dr. Lacayo currently aims to develop a classifier to predict risk of relapse and develops SCNP studies at Stanford and in collaboration with a consortium study at St. Baldrick’s. He maintains a biobank for serial acute leukemia specimens to offer samples from the same patient to allow detailed biomarker proof of principle studies at the Bass Center for Childhood Cancer and Blood Diseases. Since 2015, Dr. Lacayo has developed Phase 0 and Phase I projects in leukemia and sarcoma as institutional PI for the Pediatric Oncology Experimental Therapies Investigational Consortium (POETIC) group. Finally, in collaboration with researchers at St. Jude Children's Research Hospital, Dr. Lacayo will be the co-principal investigator in a Phase 2 national protocol for children with newly diagnosed acute myelogenous leukemia that will test the efficacy and safety of epigenetic priming in the treatment of childhood leukemia.


Michelle Monje, MD, PhD
Anne T. and Robert M. Bass Endowed Faculty Scholar (2014-2018)
Associate Professor, Neurology and, by courtesy, of Neurosurgery and of Pediatrics

Background: 
MD, Stanford University School of Medicine, 2004
PhD, Stanford University, 2004
Residency, Massachusetts General Hospital & Brigham and Women’s Hospital Harvard Medical School, 2008
Fellowship, Stanford University, 2010

Research focus: Much of brain development occurs after birth. Maturation of complex neural circuitry necessary for high-level cognitive and motor functions occurs throughout childhood and young adulthood. 
The Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. Areas of emphasis include neuronal instruction of gliogenesis (the generation of the non-neuronal connective tissue cell populations, or glia, derived from multipotent neural stem cells) and cellular contributions to the neurogenic (related to the nervous system) and gliogenic signaling microenvironment. As a practicing neurologist and neuro-oncologist, Dr. Monje is particularly interested in the roles neural precursor cell function and dysfunction play in both the origins of pediatric brain tumors and the consequences of cancer treatment.


Manpreet Singh, MD, MS
Akiko Yamazaki and Jerry Yang Faculty Scholar in Pediatric Translational Medicine (2013-2018)
Assistant Professor of Child and Adolescent Psychiatry and Development of Psychiatry & Behavioral Sciences

Education:
BS, University of Michigan, 1997 
MD, Michigan State University, 2002 
MS, University of Michigan, 2007 
Residency, Cincinnati Children’s Hospital Medical Center, 2007 
Postdoctoral Scholar, Center for Interdisciplinary Brain Sciences Research, Stanford University
School of Medicine, 2009

Research Focus:
Dr. Singh’s is the Director, Stanford Pediatric Mood Disorders Program.  Her research focuses on investigating the origins and pathways for developing major affective disorders such as depression and bipolar disorder during childhood, as well as methods to protect and preserve function before and after the onset of early emotional and behavioral problems. Using an integration of clinical, neuroimaging, genetic, and neuroendocrine tools, Dr. Singh’s research program aims to explore the complex risk factors associated with the development of emotional dysfunction and associated psychiatric disorders in children and adolescents.


Jo Wallace, PhD, LMFT, ATR-BC
Sheri Sobrato Brisson Endowed Faculty Scholar in Pediatric Neuropsychology (2015)
Clinical Assistant Professor, Neurology and Neurological Sciences

Education:
BA, Loyola University, Baltimore, MD
MA, Notre Dame de Namur University
PhD, Pacific Graduate School of Psychology 

Research focus:
Dr. Wallace specializes in cognitive late effects from tumors as well as chemotherapy and radiotherapy treatment for patients with cancer, specifically brain tumors.  Working on multiple ongoing studies through the Children’s Oncology Group, Dr. Wallace examines the neurocognitive functioning of patients at the time of diagnosis, at various points during their treatment, and post-treatment. She is also an adjunct professor for the master and doctoral psychology programs at Notre Dame de Namur University where she teaches and mentors future clinicians.  Additionally, Dr. Wallace specializes in utilizing art therapy with evidence based treatment modalities to therapeutically support the pediatric patients and families at Lucile Packard Children’s Hospital Stanford. 

Mentor: Paul Graham Fisher, MD, MHS

Past Holders